Physician profile
John Vernon Horberg
NPI 1316280647
$280,511.19
in general payments reported to CMS, 2019-2025
7 companies · $86K in 2025
The $86K reported for 2025 was more than what 95% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $519 · 2021: $141 · 2022: $78K · 2023: $68K · 2024: $47K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $104K · Consulting Fee: $75K · Travel and Lodging: $17K · Food and Beverage: $4,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $104,160.01 |
| Consulting Fee | $74,919.59 |
| Travel and Lodging | $17,324.58 |
| Food and Beverage | $4,066.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $261,097.15 | 2022-2025 | G7, Avenir, Arcos |
| Restor3d, INC. | $17,314.82 | 2023-2025 | |
| Wardlow Enterprises | $1,184.00 | 2019 | |
| Depuy Synthes Sales INC. | $741.89 | 2020-2024 | Attune |
| Smith+Nephew, INC. | $78.06 | 2022-2024 | |
| Orthalign INC | $64.02 | 2024 | Orthalign Plus |
| Shoulder Innovations, INC. | $31.25 | 2025 | Inset System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Horberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.